Max Healthcare Institute Limited (MAXHEALTH) — Financial Results | 13 August 2025

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare reported Q1 FY2025-26 consolidated revenue of ₹2,027.57 crores with net profit of ₹307.97 crores (EPS: ₹3.17). The NCLT approved the merger of subsidiaries CRL and JHL on July 31, 2025, expected to unlock synergies. The company acquired 100% stake in JHL for ₹624.70 crores and is expanding with a 130-bed super-specialty hospital in Dehradun (₹170-200 crore investment, commissioning 2028) and acquiring ~4,000 sq.meter land in Ghaziabad for ~150 additional beds. Existing network utilization remains strong at >76%.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day